Pharmasonics
Pharmasonics is a Sunnyvale, California-based medical device company that developed therapeutic ultrasound catheter-based technology. Founded in 1995, the company is privately held with 11–50 employees and last raised capital in 1998.
- Company typePrivate
- Founded1995
- HeadquartersSunnyvale, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Pharmasonics firmographics
Firmographics- Name
- Pharmasonics
- Website
- https://pharmasonics.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharmasonics is a Sunnyvale, California-based medical device company that developed therapeutic ultrasound catheter-based technology. Founded in 1995, the company is privately held with 11–50 employees and last raised capital in 1998.
- Ownership category
- akta.pro rank
Where Pharmasonics is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Markets served
Pharmasonics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pharmasonics product offering
Product offeringCore offering
Pharmasonics develops therapeutic ultrasound catheter-based technology for medical applications. The company focuses on catheter-delivered ultrasound energy as a therapeutic modality, with Sunnyvale, California as its base of operations. No specific named products, indications, or commercialization stage can be confirmed because the company website is currently parked and no active product information is accessible.
Differentiator
Problem solved
Functional benefit
Companies that use Pharmasonics
Customer profileIdeal customer profiles1 record
Pharmasonics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharmasonics competitors and assessment
Company assessmentDirect peers
- Penumbra: Penumbra manufactures catheter-based mechanical thrombectomy and aspiration systems for vascular and neurovascular indications, directly competing in the same procedural niches (clot removal, vascular intervention) that Pharmasonics' ultrasound catheter was designed to address.
- Inari Medical: Inari Medical develops catheter-based therapeutic devices (FlowTriever, ClotTriever) for venous thromboembolism and other vascular conditions, addressing the same therapeutic indications Pharmasonics' ultrasound catheter was designed to treat.
- Omnisonics Medical Technologies: Historical direct peer that developed ultrasonic catheter technology for vascular thrombectomy applications in the same era as Pharmasonics. Both companies pursued the late-1990s concept of catheter-delivered ultrasonic energy to disrupt or treat thrombus.
- EKOS Corporation (now part of Boston Scientific): EKOS developed catheter-based therapeutic ultrasound systems (EKOS EkoSonic) for ultrasound-assisted thrombolysis, the most directly comparable product and category to Pharmasonics' therapeutic ultrasound catheter technology. EKOS was acquired by BTG and subsequently integrated into Boston Scientific.
Broad incumbents
- AngioDynamics: AngioDynamics manufactures a broad portfolio of interventional medical devices, including catheter-based therapies (e.g., NanoKnife, AngioVac) for vascular and oncology indications that overlap with Pharmasonics' therapeutic catheter area but span a wider portfolio.
- Teleflex (Vascular Solutions): Teleflex, through its acquisition of Vascular Solutions, develops and commercializes interventional vascular products including specialty catheters and therapeutic devices that overlap with the catheter-based therapeutic space where Pharmasonics operated.
Others
- Surmodics: Surmodics provides hydrophilic and drug-coated catheter surface technologies used in delivery systems, relevant to Pharmasonics as an enabling technology provider in the catheter-based therapeutic device supply chain rather than a direct competitor.
Market position
Customer concentration
Pharmasonics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmasonics leadership team
Management profileNumber of profiles
Pharmasonics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmasonics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmasonics
What does Pharmasonics do?
Pharmasonics develops therapeutic ultrasound catheter-based technology for medical applications. The company focuses on catheter-delivered ultrasound energy as a therapeutic modality, with Sunnyvale, California as its base of operations. No specific named products, indications, or commercialization stage can be confirmed because the company website is currently parked and no active product information is accessible.
When was Pharmasonics founded?
Pharmasonics was founded in 1995. It employs 11 to 50 people.
Where is Pharmasonics based?
Pharmasonics is headquartered in Sunnyvale, United States, in the North America region.
Who are Pharmasonics's main competitors?
Direct peers on record are Penumbra, Inari Medical, Omnisonics Medical Technologies and EKOS Corporation (now part of Boston Scientific). Broad incumbents are AngioDynamics and Teleflex (Vascular Solutions). Surmodics is listed as an others.
Does Pharmasonics have an API?
No public API is recorded for Pharmasonics.